HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reza Jahan Selected Research

Time-to-Treatment

1/2020The impact of general anesthesia, baseline ASPECTS, time to treatment, and IV tPA on intracranial hemorrhage after neurothrombectomy: pooled analysis of the SWIFT PRIME, SWIFT, and STAR trials.
1/2019Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.
6/2016Analysis of Workflow and Time to Treatment and the Effects on Outcome in Endovascular Treatment of Acute Ischemic Stroke: Results from the SWIFT PRIME Randomized Controlled Trial.
7/2013The hyperdense vessel sign on CT predicts successful recanalization with the Merci device in acute ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Reza Jahan Research Topics

Disease

77Ischemic Stroke
11/2023 - 01/2002
54Stroke (Strokes)
11/2023 - 06/2003
17Aneurysm (Aneurysms)
10/2023 - 05/2003
16Infarction (Infarctions)
11/2023 - 10/2009
9Intracranial Aneurysm (Cerebral Aneurysm)
08/2019 - 11/2006
9Thrombosis (Thrombus)
01/2018 - 11/2003
8Cerebral Infarction
11/2021 - 05/2010
8Brain Ischemia (Cerebral Ischemia)
01/2018 - 12/2004
5Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2023 - 12/2002
5Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2021 - 10/2015
5Hemorrhage
01/2017 - 10/2009
5Pathologic Constriction (Stenosis)
01/2014 - 04/2002
3Atrial Fibrillation
01/2021 - 06/2016
3Ischemia
01/2020 - 07/2010
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2012 - 10/2010
2Hyperglycemia
11/2018 - 01/2016
2Edema (Dropsy)
10/2018 - 01/2018
2Neoplasms (Cancer)
06/2018 - 02/2017
2Hypertension (High Blood Pressure)
07/2014 - 12/2010
2Hematoma
07/2012 - 02/2012
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2010 - 11/2006
2Cerebral Hemorrhage
01/2009 - 01/2002
2Fibrosis (Cirrhosis)
07/2007 - 03/2006
1Meningioma (Meningiomas)
06/2018
1Neurologic Manifestations (Neurological Manifestations)
03/2017
1Arteriovenous Malformations (Arteriovenous Malformation)
02/2017
1Arteriovenous Fistula
02/2017
1Osteoradionecrosis
06/2013
1Aphasia (Dysphasia)
01/2013
1Hemiplegia (Spastic Hemiplegia)
01/2013
1Leukoaraiosis
07/2012
1Vertebrobasilar Insufficiency
02/2012
1Intracranial Arteriosclerosis (Cerebral Atherosclerosis)
01/2012
1Body Weight (Weight, Body)
10/2010
1Fistula
10/2010
1Ruptured Aneurysm
04/2010
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2009
1Hyperlipidemias (Hyperlipidemia)
01/2009
1Embolism (Embolus)
12/2004

Drug/Important Bio-Agent (IBA)

16Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021 - 06/2003
4Glucose (Dextrose)FDA LinkGeneric
11/2018 - 07/2014
4Biomarkers (Surrogate Marker)IBA
06/2018 - 01/2008
4PlatinumIBA
02/2017 - 12/2008
3Cytidine Triphosphate (CTP)IBA
11/2023 - 01/2017
3Indicators and Reagents (Reagents)IBA
01/2020 - 11/2003
3Fibrinolytic Agents (Antithrombotic Agents)IBA
10/2010 - 06/2005
2Blood Glucose (Blood Sugar)IBA
07/2014 - 03/2014
2FibrinIBA
07/2013 - 08/2006
2Phenobarbital (Luminal)FDA Link
01/2012 - 05/2010
2FibrinolysinFDA Link
08/2011 - 10/2010
2PolymersIBA
07/2010 - 12/2009
2serpentine (alkaloid)IBA
06/2008 - 11/2006
2Collagen Type IV (Type IV Collagen)IBA
07/2007 - 03/2006
1Oxygen (Dioxygen)IBA
01/2020
1SiliconesIBA
08/2019
1Anesthetics (Anesthetic Agents)IBA
01/2018
1Adenosine Diphosphate (ADP)IBA
02/2016
1Retinaldehyde (Retinal)IBA
01/2013
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2012
1antineoplaston A10 (A 10)IBA
01/2012
1Warfarin (Coumadin)FDA LinkGeneric
01/2012
1fibrin fragment D (D-dimer)IBA
08/2011
1Plasminogen Activators (Plasminogen Activator)IBA
10/2010
1ThrombinFDA Link
10/2010
1Hemostatics (Antihemorrhagics)IBA
10/2010
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2009
1GadoliniumIBA
01/2008
1AnticoagulantsIBA
08/2006
1CollagenIBA
03/2006
13-hydroxy-7-methylcholanoic acid (HMCA)IBA
11/2003

Therapy/Procedure

58Thrombectomy
11/2023 - 10/2009
52Therapeutics
11/2020 - 12/2002
24Stents
01/2021 - 04/2002
7Endovascular Procedures
10/2023 - 11/2006
7Embolectomy
10/2018 - 12/2004
6Catheters
01/2019 - 11/2003
4Time-to-Treatment
01/2020 - 07/2013
3Aftercare (After-Treatment)
03/2023 - 04/2010
3Punctures
01/2021 - 01/2019
2Ligation
10/2023 - 09/2023
2Cerebral Revascularization
10/2023 - 12/2009
1General Anesthesia
01/2020
1Blood Transfusion (Blood Transfusions)
06/2018
1Treatment Delay
12/2017
1Free Tissue Flaps
06/2013
1Off-Label Use
01/2012
1Organ Transplantation
07/2010
1Length of Stay
10/2009
1Endovascular Aneurysm Repair
12/2008
1Surgical Instruments (Clip)
12/2005
1Thrombolytic Therapy
01/2002
1Contraindications
01/2002